Recent decades have witnessed a rise in the emergence of new viruses posing global public health threats, such as SARS-CoV-2, Zika virus, and Ebola virus. These threats have necessitated the adoption of advanced strategies for developing effective and rapidly deployable vaccines. This article highlights key modern strategies employed in vaccine design against emerging viruses, including DNA-based vaccines, recombinant protein vaccines, nanoparticle technology, and the use of artificial intelligence and computer modeling. Emerging viruses present major challenges in virology and immunology due to their ability to evolve rapidly and jump between species. Addressing these challenges requires the adoption of modern approaches that surpass traditional vaccine development methods in terms of speed, efficiency, and safety. First: Genetic Vaccines (DNA and mRNA): DNA-based vaccines represent a significant leap forward in the world of vaccines, as they utilize genetic code to produce viral proteins that stimulate an immune response. Successful examples of this type include mRNA vaccines used against COVID-19 (such as those developed by Pfizer and Moderna). Second: Recombinant Protein Vaccines: These are produced by inserting the virus's gene into host cells to generate viral proteins that act as antigens. This method is considered relatively safe, especially for immunocompromised patients. Third: Nanoparticle Technology: This involves designing nanoparticles that mimic the actual virus in shape and size, allowing for efficient activation of the immune system without the need for a live or attenuated virus. Fourth: Artificial Intelligence and Computer Modeling: Artificial intelligence techniques are used to analyze the molecular structure of viruses and quickly identify optimal antigens. Computer modeling also helps simulate the immune response and predict vaccine efficacy before clinical trials. Fifth: Viral Vector Vaccines: These vaccines use modified viruses (such as adenoviruses) to carry the genes of the target virus. An example is the AstraZeneca vaccine against COVID-19. Modern vaccine design strategies have proven their ability to keep pace with the rapid evolution of emerging viruses. As the pandemic continues to pose challenges, these technologies are expected to play a crucial role in safeguarding global health and developing vaccines tailored to each new virus that emerges in the future. Keywords: Modern vaccines, emerging viruses, mRNA, nanoparticles, artificial intelligence, viral vectors. Al-Mustaqbal University, the leading university in Iraq.